Transgene S.A. Sustainability Reports

Transgene S.A. is a biotechnology company focused on designing and developing virus-based immunotherapies for the treatment of cancer. The company utilizes specialized technology platforms to engineer personalized therapeutic vaccines and oncolytic viruses intended to stimulate a patient's immune system against cancer cells.

Sector: Professional & technical services

Country: France

Exchange: Euronext Paris

ISIN: FR0005175080

11 reports from 2014 to 2024

• Transgene S.A. 2024 Universal Registration Document
• Transgene S.A. 2023 Universal Registration Document
• Transgene S.A. 2022 Universal Registration Document
• Transgene S.A. 2021 Universal Registration Document
• Transgene S.A. 2020 Universal Registration Document